British drugmaker AstraZeneca Plc told Reuters on Tuesday that its COVID19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.